| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036598833 |
| P356 | DOI | 10.1186/S12936-015-1058-8 |
| P932 | PMC publication ID | 4706704 |
| P698 | PubMed publication ID | 26747132 |
| P5875 | ResearchGate publication ID | 289693311 |
| P50 | author | Michele D Spring | Q94679287 |
| Chanthap Lon | Q102205362 | ||
| Evelina Angov | Q107291505 | ||
| P2093 | author name string | Sheetij Dutta | |
| David L Saunders | |||
| Panita Gosi | |||
| Sabaithip Sriwichai | |||
| Sathit Pichyangkul | |||
| Utaiwan Srichairatanakul | |||
| Douglas S Walsh | |||
| Soklyda Chann | |||
| Suwanna Chaorattanakawee | |||
| Char Meng Chour | |||
| Satharath Prom | |||
| Kosol Yongvanichit | |||
| Chaiyaporn Chaisatit | |||
| Amporn Limsalakpeth | |||
| Montida Auayapon | |||
| P2860 | cites work | A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area. | Q37617688 |
| Fighting the good fight: the role of militaries in malaria elimination in Southeast Asia | Q38279488 | ||
| Limbic encephalopathy and central vestibulopathy caused by mefloquine: A case report | Q41929827 | ||
| Protection against a malaria challenge by sporozoite inoculation | Q41937865 | ||
| Characteristics of natural antibody responses to the circumsporozoite protein of Plasmodium vivax | Q43493841 | ||
| Malaria anticircumsporozoite antibodies in dutch soldiers returning from sub‐saharan africa | Q44138417 | ||
| Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine | Q44438134 | ||
| Efficacy of monthly tafenoquine for prophylaxis of Plasmodium vivax and multidrug-resistant P. falciparum malaria | Q45056153 | ||
| Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial | Q28541521 | ||
| Genome-Scale Protein Microarray Comparison of Human Antibody Responses in Plasmodium vivax Relapse and Reinfection | Q28606685 | ||
| Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia | Q30637153 | ||
| Spatial and temporal epidemiology of clinical malaria in Cambodia 2004-2013. | Q30660664 | ||
| Safety, tolerability, and compliance with long-term antimalarial chemoprophylaxis in American soldiers in Afghanistan | Q32944212 | ||
| Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivax | Q33533328 | ||
| Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects | Q33613720 | ||
| The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen | Q33638725 | ||
| Purification, characterization, and immunogenicity of a disulfide cross-linked Plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli | Q34008897 | ||
| The human immune response to Plasmodium falciparum includes both antibodies that inhibit merozoite surface protein 1 secondary processing and blocking antibodies | Q34131183 | ||
| Immunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysis | Q34234390 | ||
| Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection | Q34687174 | ||
| Plasmodium falciparum infection during suppressive prophylaxis with mefloquine does not induce an antibody response to merozoite surface protein-1(42) | Q34875849 | ||
| Cytokine profiling in immigrants with clinical malaria after extended periods of interrupted exposure to Plasmodium falciparum | Q34965621 | ||
| Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. | Q35505807 | ||
| Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors | Q35741357 | ||
| Using Amplicon Deep Sequencing to Detect Genetic Signatures of Plasmodium vivax Relapse | Q35993493 | ||
| New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women | Q36330969 | ||
| Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection | Q36411599 | ||
| Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria | Q36594057 | ||
| Results from tandem Phase 1 studies evaluating the safety, reactogenicity and immunogenicity of the vaccine candidate antigen Plasmodium falciparum FVO merozoite surface protein-1 (MSP1(42)) administered intramuscularly with adjuvant system AS01. | Q36639261 | ||
| Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children | Q36862490 | ||
| Pre-erythrocytic antibody profiles induced by controlled human malaria infections in healthy volunteers under chloroquine prophylaxis | Q36972498 | ||
| Serology: a robust indicator of malaria transmission intensity? | Q36995780 | ||
| Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki | Q37052790 | ||
| Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia | Q37315145 | ||
| Inhibitory antibodies specific for the 19-kilodalton fragment of merozoite surface protein 1 do not correlate with delayed appearance of infection with Plasmodium falciparum in semi-immune individuals in Vietnam | Q37355849 | ||
| Outdoor malaria transmission in forested villages of Cambodia | Q37359417 | ||
| Mefloquine neurotoxicity: a literature review | Q37378828 | ||
| Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives | Q37557832 | ||
| P921 | main subject | Cambodia | Q424 |
| P304 | page(s) | 17 | |
| P577 | publication date | 2016-01-08 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Antibody profiles to plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study | |
| P478 | volume | 15 |
| Q90049684 | Assessment of subpatent Plasmodium infection in northwestern Ethiopia | cites work | P2860 |
Search more.